The KIT gene is an ideal candidate for this model since, in compound Kit heterozygous mice (W/WV and Sl/Sld animals) with partial loss-of-function mutations in Kit receptors or the Kit ligand, ICC fail to develop in various regions of the GI tract. This evidence concerns the gene KIT and intrahepatic cholangiocarcinoma.